CTSA Postdoctoral T32 at University of Colorado Denver

CTSA 博士后 T32 科罗拉多大学丹佛分校

基本信息

  • 批准号:
    10619719
  • 负责人:
  • 金额:
    $ 37.6万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-09-18 至 2028-06-30
  • 项目状态:
    未结题

项目摘要

Project Summary/Abstract. Clinician scientists fulfil a unique role by integrating discovery science with clinical practice and therapeutic intervention. However, their numbers are in decline, creating the need for flexible training and research opportunities to ensure their future. The Colorado Clinical and Translational Sciences Institute’s (CCTSI) T32 Post-Doctoral Program will address the need for highly qualified and competent translational scientists by providing a responsive and evidence-informed program, a stimulating environment with well-equipped facilities, a community of practice for translational scientists, and the explicit value that Diversity Accelerates Research and Translation (DART). We request support for 4 post-doctoral trainee slots of two years each. Our program is novel in that it expands the translational spectrum by recognizing the importance of shared, naturally occurring models of disease among animals and humans to push discovery, which we coin T0.5. Our program will involve both doctorally prepared clinicians (physicians (MD), pharmacists (PharmD), physical therapists (DPT), nurses (DPN) and others) at the University of Colorado who will complete the Master of Science in Clinical Science (MSCS) degree and veterinarians completing a PhD from Colorado State University, a partnering university. Trainees of our interprofessional program will be highly qualified and thoroughly prepared to be effective team members and translational scientists that fuel discovery that is translated to communities for improved health and lives of its citizens. Development of translational scientists that characterize Domain Expert, Rigorous Researcher, Boundary Crosser, Process Innovator, Team Player, Skilled Communicator, and Systems Thinker will be emphasized through completion of a degree program (MSCS or PhD), meaningful immersion experiences for translational science and translational research, effective mentorship and peer support, and alleviating “pull factors” by creating a community of practice through our Translational Scientist seminars. Pull factors are demands that compete or conflict with trainee engagement, integration, and performance that ultimately diminish persistence. Clinical and translational science and research requires a shift from an individual-based approach to a teamwork model. Team member competency development will be kick-started by early participation in our Teaming and Leading program. The One Health framework will be used to highlight the need for teaming and permit application of all translational scientist competencies recognizing that achievement of optimal health is reliant on the interconnection among people, animals, and their shared environment across eco-health system levels (local, regional, national and global). A culminating activity will be trainee led interdisciplinary teams participating in a One Health Hackathon focused on antimicrobial resistance. Long term-evaluation and continuous quality improvement will be used to guide programmatic efforts and respond to changing demands. Evaluative efforts will focus on the program’s ability to develop a diverse group of persistent team oriented translational scientists.
项目摘要/摘要。 临床科学家通过将发现科学与临床实践和治疗相结合来发挥独特的作用 然而,他们的数量正在下降,因此需要灵活的培训和研究。 确保他们未来的机会。科罗拉多临床和转化科学研究所 (CCTSI) T32 博士后计划将通过以下方式满足对高素质和有能力的转化科学家的需求 提供反应灵敏、循证的计划、具有设备齐全设施的激励性环境, 转化科学家的实践社区,以及多样性加速研究的明确价值 我们请求为 4 个博士后实习生名额提供支持,每个名额为期两年。 该计划的新颖之处在于它通过认识到共享、 动物和人类自然发生的疾病模型,以推动发现,我们将其称为“我们的 T0.5”。 该计划将涉及博士准备的教师(医师(MD)、药剂师(PharmD)、物理师) 科罗拉多大学的治疗师(DPT)、护士(DPN)和其他),他们将完成以下硕士学位: 临床科学科学 (MSCS) 学位和兽医在科罗拉多州完成博士学位 大学是我们的合作大学,我们的跨专业项目的学员将是高素质和高素质的。 充分准备好成为有效的团队成员和转化科学家,推动发现 转化为社区,以改善其公民的健康和生活。 具有领域专家、严谨研究员、跨界者、流程创新者、团队合作者的特征, 通过完成学位课程将强调熟练的沟通者和系统思考者 (MSCS 或博士),转化科学和转化研究的有意义的沉浸式体验, 有效的指导和同伴支持,并通过创建实践社区来减轻“拉动因素” 通过我们的转化科学家研讨会,拉动因素是与实习生竞争或冲突的要求。 参与、整合和绩效最终会降低临床和转化。 科学研究需要从基于个人的方法转变为团队成员的合作模式。 早期参与我们的团队和领导计划将启动能力发展。 “同一个健康”框架将用于强调团队合作的必要性并允许应用所有转化 科学家的能力认识到健康的最佳实现依赖于之间的相互联系 人、动物及其在生态卫生系统各个层面(地方、区域、国家和 全球)的一项高潮活动是由实习生领导的跨学科团队参加 One Health 黑客马拉松。 将重点关注抗菌素耐药性的长期评估和持续的质量改进。 指导计划工作并响应不断变化的需求。评估工作将集中于计划的内容。 培养一支多元化、以团队为导向的转化科学家的能力。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Lisa Cicutto其他文献

Lisa Cicutto的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Lisa Cicutto', 18)}}的其他基金

CTSA Predoctoral T32 at University of Colorado Denver
CTSA 博士前 T32 科罗拉多大学丹佛分校
  • 批准号:
    10619731
  • 财政年份:
    2023
  • 资助金额:
    $ 37.6万
  • 项目类别:
Addressing Social Determinants of Health in Disadvantaged Children with Asthma
解决患有哮喘的弱势儿童健康的社会决定因素
  • 批准号:
    10321174
  • 财政年份:
    2020
  • 资助金额:
    $ 37.6万
  • 项目类别:
Reducing Asthma Attacks in Disadvantaged School Children with Asthma
减少患有哮喘的弱势学童的哮喘发作
  • 批准号:
    10063661
  • 财政年份:
    2020
  • 资助金额:
    $ 37.6万
  • 项目类别:
Reducing Asthma Attacks in Disadvantaged School Children with Asthma
减少患有哮喘的弱势学童的哮喘发作
  • 批准号:
    10723244
  • 财政年份:
    2020
  • 资助金额:
    $ 37.6万
  • 项目类别:
Reducing Asthma Attacks in Disadvantaged School Children with Asthma
减少患有哮喘的弱势学童的哮喘发作
  • 批准号:
    10470434
  • 财政年份:
    2020
  • 资助金额:
    $ 37.6万
  • 项目类别:
Reducing Asthma Attacks in Disadvantaged School Children with Asthma
减少患有哮喘的弱势学童的哮喘发作
  • 批准号:
    10470858
  • 财政年份:
    2020
  • 资助金额:
    $ 37.6万
  • 项目类别:
Reducing Asthma Attacks in Disadvantaged School Children with Asthma
减少患有哮喘的弱势学童的哮喘发作
  • 批准号:
    10254414
  • 财政年份:
    2020
  • 资助金额:
    $ 37.6万
  • 项目类别:
NRSA Training Core
NRSA 培训核心
  • 批准号:
    9926130
  • 财政年份:
    2018
  • 资助金额:
    $ 37.6万
  • 项目类别:
NRSA Training Core
NRSA 培训核心
  • 批准号:
    10399663
  • 财政年份:
    2018
  • 资助金额:
    $ 37.6万
  • 项目类别:

相似国自然基金

中国博士后战略发展与改革研究
  • 批准号:
    71273034
  • 批准年份:
    2012
  • 资助金额:
    38.0 万元
  • 项目类别:
    面上项目
中国博士后制度的制度分析与机制创新研究
  • 批准号:
    70873010
  • 批准年份:
    2008
  • 资助金额:
    23.0 万元
  • 项目类别:
    面上项目
博士后评估理论与技术研究
  • 批准号:
    70640002
  • 批准年份:
    2006
  • 资助金额:
    5.0 万元
  • 项目类别:
    专项基金项目

相似海外基金

23rd Annual Rocky Mountain Virology Association Conference
第 23 届落基山病毒学协会年度会议
  • 批准号:
    10753094
  • 财政年份:
    2023
  • 资助金额:
    $ 37.6万
  • 项目类别:
The Role of IMAT Inflammatory Secretome on Muscle Insulin Resistance
IMAT 炎症分泌组对肌肉胰岛素抵抗的作用
  • 批准号:
    10749725
  • 财政年份:
    2023
  • 资助金额:
    $ 37.6万
  • 项目类别:
Prenatal and early-life black carbon exposure and childhood cardiometabolic health
产前和生命早期的黑碳暴露与儿童心脏代谢健康
  • 批准号:
    10604098
  • 财政年份:
    2023
  • 资助金额:
    $ 37.6万
  • 项目类别:
29th Annual Midwest Microbial Pathogenesis Conference (MMPC)
第 29 届年度中西部微生物发病机制会议 (MMPC)
  • 批准号:
    10750604
  • 财政年份:
    2023
  • 资助金额:
    $ 37.6万
  • 项目类别:
2023 Physics and Chemistry of Microfluidics Gordon Research Conference and Gordon Research Seminar
2023年微流控物理与化学戈登研究会议暨戈登研究研讨会
  • 批准号:
    10681683
  • 财政年份:
    2023
  • 资助金额:
    $ 37.6万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了